Literature DB >> 907253

Methotrexate and hemodialysis.

K R Hande, J E Balow, J C Drake, S A Rosenberg, B A Chabner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 907253     DOI： 10.7326/0003-4819-87-4-495_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

Review 1.  Methotrexate for rheumatoid arthritis patients who are on hemodialysis.

Authors:  Hasanein Al-Hasani; Euthalia Roussou
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

2.  Removal of methotrexate by hemodiafiltration.

Authors:  N Montagne; G Milano; C Caldani; J Bracco; P Ayela; E Cassuto; A Thyss; M Schneider
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results.

Authors:  R B Jones; C E Myers; A M Guarino; R L Dedrick; S M Hubbard; V T DeVita
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

4.  Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Marc Ghannoum; Darren M Roberts; David S Goldfarb; Jesper Heldrup; Kurt Anseeuw; Tais F Galvao; Thomas D Nolin; Robert S Hoffman; Valery Lavergne; Paul Meyers; Sophie Gosselin; Tudor Botnaru; Karine Mardini; David M Wood
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-02       Impact factor: 10.614

Review 5.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

6.  Clinical use of thymidine as a rescue agent from methotrexate toxicity.

Authors:  J L Grem; S A King; J M Sorensen; M C Christian
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.